Cited by 1,179SARS-CoV-2 and COVID-19 ResearchEvolution and Genetic DynamicsAnimal Virus Infections Studies

The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.

The evolution of SARS-CoV-2

Open access

Markov, Peter V., Ghafari, Mahan, Beer, Martin, Lythgoe, Katrina, Simmonds, Peter, Stilianakis, Nikolaos I., Katzourakis, Aris·2023·Nature Reviews Microbiology

DOI 10.1038/s41579-023-00878-2

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41579-023-00878-2

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
EVOLUTION IN MENDELIAN POPULATIONS
Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154

Show all 225 references

Sorted by citations

Items 301–400 of 998

Wave succession in the pandemic clone of Vibrio parahaemolyticus driven by gene loss
Yang, C., Qiu, H., Svensson, S. L., Ni, C., Gao, S., Jia, Z., Wen, H., Xie, L. X., Xu, W., Qin, Y., et al. (2025) · Nature Ecology & Evolution · doi:10.1038/s41559-025-02827-z · Cited by 6
Rapid, On-Site SARS-CoV-2 Variant Detection and Differentiation Using GLAD-Pristine Silver Nanorod Arrays and Machine Learning-Enhanced SERS
Senapati, S., Kaushik, A., Rajan, Singh, A., Gupta, I., Virkar, R., Kulkarni, S., Arankalle, V., & Singh, J. P. (2025) · ACS Omega · doi:10.1021/acsomega.5c02860 · Cited by 7
Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV
Xu, J., Chamblee, M., Jiang, F., Mahesh, K. C., Hsu, C. C., Thongpan, I., Chen, P., Zhang, Y., Chiu, C.-T., Shamseldin, M. M., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx7487 · Cited by 7
Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
Liu, H., Xu, Z., Karsidag, I., Wang, P., & Weng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1689507 · Cited by 7
Incidence of respiratory infections after the COVID-19 pandemic (2023-2024) and its association of vaccination among entire populations in Korea
Song, J., Jeong, S., Chun, A. Y., Jung, J., Park, S. J., & Park, S. M. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108194 · Cited by 6
Functional and structural basis of Omicron BA.3.2.1 spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P., Liang, B., & Xie, X. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117812 · Cited by 6
Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry
Dabrell, S. N., Li, Y., Yamaguchi, H., Chen, H., & Hung, M. (2023) · Biomedicines · doi:10.3390/biomedicines11112914 · Cited by 6
Natural products from Streptomyces spp. as potential inhibitors of the major factors (holoRdRp and nsp13) for SARS-CoV-2 replication: an in silico approach
Kumar, P., Parveen, P., Raj, N., Kumar, M., Fakhri, K. U., Kumar, S., Khan, A. A., Alanazi, A. M., Solanki, R., Harsha, H., et al. (2024) · Archives of Microbiology · doi:10.1007/s00203-023-03820-5 · Cited by 6
Dietary habits, traveling and the living situation potentially influence the susceptibility to SARS-CoV-2 infection: results from healthcare workers participating in the RisCoin Study
Wratil, P. R., Thi, T. G. L., Osterman, A., Badell, I., Huber, M., Zhelyazkova, A., Wichert, S. P., Litwin, A., Hörmansdorfer, S., Strobl, F., et al. (2024) · Infection · doi:10.1007/s15010-024-02201-4 · Cited by 6
Efficient overexpression and purification of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteins in Escherichia coli
Brudenell, E. L., Pohare, M. B., Zafred, D., Phipps, J., Hornsby, H. R., Darby, J. F., Dai, J., Liggett, E., Cain, K. M., Barran, P. E., et al. (2024) · Biochemical Journal · doi:10.1042/bcj20240019 · Cited by 6
Bayesian inference for the onset time and epidemiological characteristics of emerging infectious diseases
Shi, B., Yang, S., Tan, Q., Zhou, L., Yang, L., Zhou, X., & Liu, J. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1406566 · Cited by 7
Revolutionizing Veterinary Health with Viral Vector-Based Vaccines
Jogi, H. R., Smaraki, N., Rajak, K. K., Yadav, A. K., Bhatt, M., Einstien, C., Revathi, A., Thakur, R., Kamothi, D. J., Dedeepya, P., et al. (2024) · Indian Journal of Microbiology · doi:10.1007/s12088-024-01341-3 · Cited by 6
Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study
Aleksandra, N., Lee, S. M., Kim, M., Chun, J., Kim, S., Kim, B. C., In, H. J., Lee, E., Lee, C., Lee, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1359209 · Cited by 6
Exposure to obinutuzumab does not affect outcomes of SARS ‐ CoV ‐2 infection in vaccinated patients with newly diagnosed advanced‐stage follicular lymphoma
Pinto, A., Caltagirone, M., Battista, M., Gazzoli, G. C., Patti, C., Pennese, E., Lorenzo, S. D., Pavone, V., Merli, M., Chiarenza, A., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19661 · Cited by 6
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity
Ramírez, M. A., Loaiza, R. A., Martínez-Balboa, Y., Bruneau, N., Ramírez, E., V, González, P. A., Bueno, S. M., & Kalergis, A. M. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126203 · Cited by 6
Impact and Effectiveness of COVID-19 Vaccines Based on Machine Learning Analysis of a Time Series: A Population-Based Study
Carretero, R. G., Ordoñez-Garcia, M., Gómez, O. V., Rodriguez-Maya, B., Gil-Prieto, R., & de Miguel, Á. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195890 · Cited by 6
What COVID-19 Vaccination Strategy Should Be Implemented and Which Vaccines Should Be Used in the Post-Pandemic Era?
Plans-Rubió, P. (2024) · Vaccines · doi:10.3390/vaccines12101180 · Cited by 6
Cross-Section of Neurological Manifestations Among SARS-CoV-2 Omicron Subvariants—Single-Center Study
Jachman-Kapułka, J., Zińczuk, A., Simon, K. A., & Rorat, M. (2024) · Brain Sciences · doi:10.3390/brainsci14111161 · Cited by 6
Structure and dynamics of the interaction of Delta and Omicron BA.1 SARS-CoV-2 variants with REGN10987 Fab reveal mechanism of antibody action
Lyukmanova, E. N., Pichkur, E., Nolde, D. E., Kocharovskaya, M. V., Manuvera, V. A., Shirokov, D. A., Kharlampieva, D. D., Grafskaia, E. N., Svetlova, J. I., Лазарев, В. Н., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07422-9 · Cited by 6
Bat coronavirus surveillance across different habitats in Yucatán, México
Jiménez-Rico, M. A., Vigueras-Galván, A. L., Hernández-Villegas, E. N., Martínez-Duque, P., Roiz, D., Falcón, L. I., Vázquez‐Domínguez, E., Gaona, O., Arnal, A., Roche, B., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110401 · Cited by 6
Paying attention to the SARS-CoV-2 dialect : a deep neural network approach to predicting novel protein mutations
Elkin, M. E., & Xingquan Zhu, A. (2025) · Communications Biology · doi:10.1038/s42003-024-07262-7 · Cited by 6
SARS-CoV-2 outbreak in lions, tigers, and hyenas at Denver Zoo
Gallichotte, E. N., Bashor, L., Erbeck, K., Croft, L., Stache, K., Long, J., VandeWoude, S., Johnson, J., Pabilonia, K. L., & Ebel, G. D. (2025) · mSphere · doi:10.1128/msphere.00989-24 · Cited by 6
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape
Zhu, F., Rajan, S., Hayes, C. F., Kwong, K. Y., Gonçalves, A. R., Zemla, A. T., Lau, E. Y., Zhang, Y., Caì, Y., Goforth, J. W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu0718 · Cited by 6
COVID Variants, Villain and Victory: A Bioinformatics Perspective
Shukla, N., Srivastava, N., Gupta, R., Srivastava, P., & Narayan, J. (2023) · Microorganisms · doi:10.3390/microorganisms11082039 · Cited by 6
Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?
Korosec, C. S., Wahl, L. M., & Heffernan, J. M. (2024) · Virus Evolution · doi:10.1093/ve/veae006 · Cited by 6
Second-Generation SARS-CoV-2 Recombinants: Lessons from Other Viruses
Focosi, D., & Maggi, F. (2023) · Viruses · doi:10.3390/v15051063 · Cited by 6
Wastewater as a back door to serology?Preprint
Agan, M. L., Taylor, W. R., Young, I., Willis, W. A., New, G., Lair, H., Murphy, A., Marinelli, A., Juel, M. A. I., Munir, M., et al. (2022) · medRxiv · doi:10.1101/2022.11.11.22282224 · Cited by 8
Influence of Prior SARS-CoV-2 Infection on COVID-19 Severity: Evidence from the National COVID Cohort CollaborativePreprint
Hendrix, N., Sidky, H., & Sahner, D. (2023) · medRxiv · doi:10.1101/2023.08.03.23293612 · Cited by 5
Immune escape and replicative capacity of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1Preprint
Bekliz, M., Essaidi-Laziosi, M., Adea, K., Hosszu-Fellous, K., Alvarez, C., Bellon, M., Sattonnet‐Roche, P., Puhach, O., Dbeissi, D., Zaballa, M.-E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.14.579654 · Cited by 6
Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect contaminations from other strains
Suwanchaikasem, P., Rattanapisit, K., Strasser, R., & Phoolcharoen, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-59860-4 · Cited by 5
CovTransformer: A transformer model for SARS-CoV-2 lineage frequency forecasting
Feng, Y., Goldberg, E. E., Kupperman, M. D., Zhang, X., Lin, Y., & Ke, R. (2024) · Virus Evolution · doi:10.1093/ve/veae086 · Cited by 8
Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021
Su, Y. C. F., Zeller, M. A., Ou, T. P., Ma, J., Pum, L., Zhang, R., Rath, S., Heang, V., Kol, S., Lim, R., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00685-7 · Cited by 6
Chinese herbal medicine for dyspnea and persistent symptoms of long COVID: A systematic review and meta-analysis of randomized controlled trials
Tsang, M. S., Zhou, I. W., Zhang, A. L., & Xue, C. C. (2025) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2025.01.001 · Cited by 5
Barcoded SARS-CoV-2 viruses define the impact of duration and route of exposure on the transmission bottleneck in a hamster model
Trende, R., Darling, T. L., Gan, T., Wang, D., & Boon, A. C. M. (2025) · Science Advances · doi:10.1126/sciadv.ads2927 · Cited by 4
Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach
Mandal, S., Chanu, W. P., & Natarajaseenivasan, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1442101 · Cited by 5
Subcutaneous administration of an endocrine-mimetic, slow-release protein material reduces the severity of SARS-CoV-2 infection
Parladé, E., Tarrés-Freixas, F., Favaro, M. T. D. P., Lascorz, J., Márquez, M., Mendoza, R., Corchero, J. L., Cantero, G., Roca, N., Pérez, M., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106813 · Cited by 5
Respiratory infectious disease transmission of dental healthcare workers
Xiao, S., Luo, Y., Zhao, F., Dou, Z., Cao, B., Yu, H., & Zhang, N. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.138140 · Cited by 5
A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases
Miroshnichenko, M. I., Kolpakov, F., & Akberdin, I. R. (2025) · Viruses · doi:10.3390/v17050589 · Cited by 7
Behavior-driven forecasts of neighborhood-level COVID-19 spread in New York City
Zhang, R., Tai, J., Yao, Q., Yang, W., Ruggeri, K., Shaman, J. L., & Pei, S. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012979 · Cited by 5
Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study
Bodner, K., Wang, L., Kustra, R., Kwong, J. C., Sander, B., Sbihi, H., Irvine, M. A., & Mishra, S. (2025) · Nature Communications · doi:10.1038/s41467-025-59768-1 · Cited by 5
Trans amplifying mRNA vaccine expressing consensus spike elicits broad neutralization of SARS CoV 2 variants
Gontu, A., Misra, S., Chothe, S. K., Ramasamy, S., Jakka, P., Byukusenge, M., LaBella, L. C., Nair, M. S., Jayarao, B. M., Archetti, M., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01166-1 · Cited by 6
Construction of a visual lateral flow chromatographic and electrochemical immunosensor based on bimetallic Prussian blue analogue for efficiently sensing SARS-CoV-2
Hu, B., Ruan, Y., Wang, H., Shang, X., Duan, F., Guo, C., Zhang, S., & Zhang, Z. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114318 · Cited by 5
Development of a Liposome-Based Serological Assay for SARS-CoV-2 Variants with Special Emphasis on Coupling Chemistries Required to Maintain Protein Antigenicity
Streif, S., Neckermann, P., Hoecherl, K., Reiner, C., Einhauser, S., Konrad, J., Breunig, M., Wagner, R., & Baeumner, A. J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02526 · Cited by 5
Effects of individual variation and seasonal vaccination on disease risks
Hart, W. S., Amin, J., Park, H., Kitagawa, K., Jeong, Y. D., Kaye, A. R., Iwami, S., & Thompson, R. N. (2025) · Nature Communications · doi:10.1038/s41467-025-63375-5 · Cited by 5
Immunocompromised patients with persistent SARS-CoV-2 viral shedding ≥8 weeks, clinical outcomes, and virological dynamics: a retrospective multicenter cohort study, 2020–2024
Vaux, C. D. L. P. D., Veyrenche, N., Silva, K. D., Chavarot, N., Burgard, M., Paccoud, O., Runyo, F., Garzaro, M., Rouzaud, C., Serris, A., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00658-25 · Cited by 5
Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies
Marvelde, M. R. T., Mykytyn, A. Z., Kroeze, E. J. B. V., Bouffier, A., van Eck—Schipper, D., van den Doel, P., Handrejk, K., Koel, B. F., Rissmann, M., & Haagmans, B. L. (2026) · npj Vaccines · doi:10.1038/s41541-025-01348-x · Cited by 6
Two decades (2005 to 2025) of avian influenza research trends, knowledge gaps and distribution of emerging H5N1 2.3.4.4b clade in South Asia
Ali, M. Z., Edet, U. O., Salauddin, M., & Meseko, C. A. (2026) · One Health Outlook · doi:10.1186/s42522-026-00206-7 · Cited by 5
Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1–114: From Structure-Based Design to In Vivo Antiviral Efficacy
Gannarapu, M. R., Indukuri, D. R., Holberg, C., Ratia, K. M., Ramos, O. L., Cardoza, S., Velma, G. R., Musku, S. R., Qi, Z., Slilaty, S. N., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03846 · Cited by 5
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies
Lü, J., Tan, S., Gu, H., Liu, K., Huang, W., Yu, Z., Lu, G., Wu, Z., Gao, X., Zhao, J., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2321994 · Cited by 5
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
Feng, S., Reid, G., Clark, N. M., Harrington, A., Uprichard, S. L., & Baker, S. C. (2024) · Virology Journal · doi:10.1186/s12985-024-02378-y · Cited by 5
Drinking to Cope With the COVID-19 Pandemic Mediates Pathways From COVID-19 Anxiety to Alcohol Use and Alcohol Myopia Consequences
Lac, A. (2024) · Journal of Dual Diagnosis · doi:10.1080/15504263.2024.2343372 · Cited by 5
Risk of intensive care unit admission and mortality in patients hospitalized due to influenza A or B and SARS‑CoV‑2 variants Omicron or Delta
Rezahosseini, O., Roed, C., Sejdic, A., Eiberg, M. F., Nielsen, L. B., Boel, J. B., Johannesen, C. K., van Wijhe, M., Franck, K. T., Ostrowski, S. R., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1269 · Cited by 5
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants
Banho, C. Á., Marques, B. D. C., Sacchetto, L., Lima, A. K. S., Parra, M. C. P., Lima, A. R. J., Ribeiro, G., Martins, A. J., Barros, C. R. D. S., Elias, M. C., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00933-w · Cited by 6
Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea
No, J. S., Noh, J. Y., Lee, C. Y., Kim, I. H., Kim, J., Ahn, Y. J., Lee, H., Kim, J., Lee, N., Lee, D., et al. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199471 · Cited by 5
Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study
Pan, H., Chen, H., Li, W., Tian, Y., Ge, Z., Kong, W., Gu, Z., Zou, N., Zhu, H., Zhang, J., et al. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241298794 · Cited by 5
Predicting survival in patients with SARS-CoV-2 based on cytokines and soluble immune checkpoint regulators
Lee, N., Jeon, K., Park, M.-J., Song, W., & Jeong, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1397297 · Cited by 5
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness
Bilev, E., Wild, N., Momayyezi, P., Sala, B. M., Sun, R., Sandalova, T., Marquardt, N., Ljunggren, H., Achour, A., & Hammer, Q. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012755 · Cited by 5
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
Kumar, D., Gaikwad, K., Gunnale, R., Vishwakarma, S., Shukla, S., Srivastava, S., Gopal, J., Vaidya, B., Saraf, A., Gurjar, R., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01076-2 · Cited by 5
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar
Thomas, R., Zaqout, A., Meqbel, B., Jafar, U., Vaikath, N. N., Aldushain, A., Naik, A., Shaath, H., Al-Akl, N. S., Adam, A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557426 · Cited by 5
Variable rates of SARS-CoV-2 evolution in chronic infections
Smith, E. W., Hamilton, W. L., Warne, B., Walker, E. R., Jahun, A. S., Hosmillo, M. D. T., Gupta, R. K., Goodfellow, I., Gkrania‐Klotsas, E., Török, M. E., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013109 · Cited by 5
An integrated multiscale computational framework deciphers SARS-CoV-2 resistance to sotrovimab
Sharma, A., Maurya, S., Kumar, S., Tripathi, T., Kar, R. K., & Padhi, A. K. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.05.015 · Cited by 6
Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines
Joseph, J., Sethumadhavan, K., Ahlawat, P., Prakash, M., Kandpal, G., Raj, G., Srivastava, H., Charulekha, P., Dev, A. K., Radhakrishnan, A., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c06081 · Cited by 8
A medicinal chemistry overview of direct-acting antivirals approved in 2013–2024 by US FDA
Nizi, M. G., Massari, S., Tabarrini, O., & Manfroni, G. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118105 · Cited by 8
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave
Lambisia, A. W., Katama, E. N., Moraa, E., Morobe, J. M., Gallagher, K. E., Mutunga, M. N., Nyale, E., Omungala, J., Mwanga, M. J., Murunga, N., et al. (2025) · BMC Global and Public Health · doi:10.1186/s44263-025-00201-6 · Cited by 5
Naive and breakthrough infections with BA.2, BA.5 and BF.7 variants provide poor cross protection against XBB related variants
Yang, Y., Gong, X., Tang, Y., Liu, J., Zeng, L., Kuang, J., Wang, F., Liu, Y., & Liu, Y. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.05.018 · Cited by 4
Analyzing the Geometry and Dynamics of Viral Structures: A Review of Computational Approaches Based on Alpha Shape Theory, Normal Mode Analysis, and Poisson–Boltzmann Theories
Hsieh, Y.-C., Delarue, M. H., Orland, H., & Koehl, P. (2023) · Viruses · doi:10.3390/v15061366 · Cited by 6
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic
Canuti, M., Monti, M. C., Bobbio, C., Muscatello, A., Muheberimana, T., Baldi, S. L., Blasi, F., Canetta, C., Costantino, G., Nobili, A., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1260950 · Cited by 5
Trends in the COVID-19 Pandemic in Italy during the Summers of 2020 (before Mass Vaccination), 2021 (after Primary Mass Vaccination) and 2022 (after Booster Mass Vaccination): A Real-World Nationwide Study Based on a Population of 58.85 Million People
Roncati, L., Bartolacelli, G., Galeazzi, C., & Caramaschi, S. (2023) · Pathogens · doi:10.3390/pathogens12121376 · Cited by 4
Differential pathogenic and molecular features in neurological infection of SARS‐CoV‐2 Omicron BA.5.2 and BA.2.75 and Delta
Wang, E., Yang, Q., Xu, X., Zou, Q., Long, Y., Ma, G., Deng, Z., Zhao, J., Li, M., & Zeng, J. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29357 · Cited by 5
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19
Sharma, T., Mondal, T., Khan, S. A., Churqui, M. P., Nyström, K., Thombare, K., Baig, M. H., & Dong, J.-J. (2024) · Archives of Microbiology · doi:10.1007/s00203-023-03761-z · Cited by 5
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing
Ameratunga, R., Woon, S., Leung, E. Y., Lea, E., Chan, L., Mehrtens, J., Longhurst, H. J., Steele, R. H., Lehnert, K., & Lindsay, K. (2024) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2024.152387 · Cited by 5
One-pot DTECT enables rapid and efficient capture of genetic signatures for precision genome editing and clinical diagnostics
Baudrier, L., Benamozig, O., Langley, J., Chopra, S., Kalashnikova, T., Benaoudia, S., Singh, G., Mahoney, D. J., Wright, N. A. M., & Billon, P. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100698 · Cited by 5
Systematic SARS-CoV-2 S-gene sequencing in wastewater samples enables early lineage detection and uncovers rare mutations in Portugal
Reis, A. C., Pinto, D., Monteiro, S., Santos, R., Martins, J. V., Sousa, A., Páscoa, R., Lourinho, R., & Cunha, M. V. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170961 · Cited by 5
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI
Kern, A. L., Pink, I., Bonifacius, A., Kaireit, T. F., Speth, M., Behrendt, L., Klimeš, F., Voskrebenzev, A., Hohlfeld, J. M., Hoeper, M. M., et al. (2024) · European Radiology · doi:10.1007/s00330-024-10669-9 · Cited by 5
Evaluation of the Polysaccharide “Immeran” Activity in Syrian hamsters’ Model of SARS-CoV-2
Generalova, L., Laryushkin, D. P., Leneva, I. A., Ivanina, A. V., Trunova, G. V., Dolinnyi, S. V., & Generalov, E. A. (2024) · Viruses · doi:10.3390/v16030423 · Cited by 5
An evolutionary theory on virus mutation in COVID-19
Luo, L., & Lv, J. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199358 · Cited by 5
On the SARS-CoV-2 Variants
Scarpa, F., Branda, F., Petrosillo, N., & Ciccozzi, M. (2024) · Infectious Disease Reports · doi:10.3390/idr16020024 · Cited by 5
Physicochemical properties-based hybrid machine learning technique for the prediction of SARS-CoV-2 T-cell epitopes as vaccine targets
Bukhari, S. N. H., Elshiekh, E., & Abbas, M. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.1980 · Cited by 5
Confounding amplifies the effect of environmental factors on COVID-19
Hao, Z., Hu, S., Huang, J., Hu, J., Zhang, Z., Li, H., & Yan, W. (2024) · Infectious Disease Modelling · doi:10.1016/j.idm.2024.06.005 · Cited by 5
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
Murdocca, M., Romeo, I., Citro, G., Latini, A., Centofanti, F., Bugatti, A., Caccuri, F., Caruso, A., Ortuso, F., Alcaro, S., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17070891 · Cited by 5
Creatingo Co crystal salts: Synthesis, crystal structure, hirshfeld surface analysis and quantum chemical calculations of pyrimethamine and their potential anti- SARS-Cov-2 activity
Fatima, R., Farooq, S., Moin, S. T., Choudhary, M. I., & Sammer Yousuf, B. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140982 · Cited by 5
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Tort, L. F. L., de Araújo, M. F., Arantes, I., Martins, J. S. C. C., Gomes, M. F. D. C., de Carvalho, F. C., de Almeida, W. A. F., Caetano, B. C., Appolinario, L., Pereira, E. C., et al. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.100503 · Cited by 5
Risk Factors for Long-Term Nutritional Disorders One Year After COVID-19: A Post Hoc Analysis of COVID-19 Recovery Study II
Kawabata, K., Nakamura, K., Kanda, N., Hemmi, M., Suganuma, S., Muto, Y., Iba, A., Hori, M., Hosozawa, M., & Iso, H. (2024) · Nutrients · doi:10.3390/nu16234234 · Cited by 5
Strong evidence for the evolution of decreasing compositional heterogeneity in SARS-CoV-2 genomes during the pandemic
Oliver, J. L. T., Bernaola‐Galván, P., Carpena, P., Perfectti, F., Gómez‐Martín, C., Castiglione, S., Raia, P., Verdú, M., & Moya, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-95893-z · Cited by 5
Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2
Dionne, K., Tauzin, A., Bélanger, É., Desfossés, Y., Benlarbi, M., Niu, L., Beaudoin-Bussières, G., Medjahed, H., Bourassa, C., Perreault, J., et al. (2025) · Viruses · doi:10.3390/v17050666 · Cited by 5
Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
Gulova, S. M., Veselkina, U. S., & Astrakhantseva, I. V. (2025) · Vaccines · doi:10.3390/vaccines13070761 · Cited by 6
Home Isolation and Online Support Strategies during Mild COVID-19 Pandemic Waves in Thailand: A Scoping Review
Pinsawas, B., Ophakas, S., Bedavanija, A., Kochasawas, W., Jitpun, P., Leemongkol, S., Phisalprapa, P., Srivanichakorn, W., Chaisathaphol, T., Washirasaksiri, C., et al. (2023) · COVID · doi:10.3390/covid3070071 · Cited by 5
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies
Zang, T. M., Kuffour, E. O., Baharani, V. A., Canis, M., Schmidt, F., DaSilva, J., Lercher, A., Chaudhary, P., Hoffmann, H.-H., Gazumyan, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317367120 · Cited by 4
Simple, Visual, Point-of-Care SARS-CoV-2 Detection Incorporating Recombinase Polymerase Amplification and Target DNA–Protein Crosslinking Enhanced Chemiluminescence
Chen, H., Zhuang, Z., Xu, N., Feng, Y., Fang, K., Tan, C., & Tan, Y. C. (2024) · Biosensors · doi:10.3390/bios14030135 · Cited by 5
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Corominas, J., Garriga, C., Prenafeta, A., Moros, A., Cañete, M., Barreiro, A., González‐González, L., Madrenas, L., Güell, I., Clotet, B., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2024.126685 · Cited by 5
Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities
Chow, E. J., Lynch, J. B., Zerr, D. M., Riedo, F. X., Fairchok, M. P., Pergam, S. A., Baliga, C. S., Pauk, J. S., Lewis, J., & Duchin, J. S. (2023) · Annals of Internal Medicine · doi:10.7326/m23-1230 · Cited by 5
Phylogenetic meta-analysis of chronic SARS-CoV-2 infections in immunocompromised patients shows no evidence of elevated evolutionary ratesPreprint
Översti, S., Gaul, E., Jensen, B. O., & Kühnert, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.01.565087 · Cited by 5
From pandemic to endemic: Divergence of COVID-19 positive-tests and hospitalization numbers from SARS-CoV-2 RNA levels in wastewater of Rochester, Minnesota
Majumdar, R., Taye, B., Bjornberg, C., Giljork, M., Lynch, D. A., Farah, F., Abdullah, I., Osiecki, K., Yousaf, I., Luckstein, A., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27974 · Cited by 4
Viral imitation is the sincerest form of epigenetic flattery
Smith, J. R., Arellano, A. A., & Avgousti, D. C. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-04-0147 · Cited by 4
Efficient detection of SARS-CoV-2 IgG by a smartphone-based high-throughput fiber optic sensor
Wei, H., Wang, S., Wang, S., Xiao, W., Ding, A., Deng, N., & Wang, H. (2025) · Talanta · doi:10.1016/j.talanta.2025.128183 · Cited by 4
A critical review of fiber reinforced polymer bars: a scientometric and visualization analysis
Yue, Z., Ouyang, K., Yao, X., Hu, K., & Li, L. (2025) · Cleaner Materials · doi:10.1016/j.clema.2025.100325 · Cited by 4
Bioinspired Wet‐Laid Electrospun Short Fiber Hybrid Networks for Aerosol Filtration
Deng, C., Xu, Y., Silva, J. M. D. S. E., Nguyen, H. T., Santos, M. I., Song, Y., Schmalz, H., Schneider, R., Hering, A., Langner, M., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202511218 · Cited by 4
Convergent Evolution and Host-Limiting Impacts of SARS-CoV-2 Revealed by Cellular Experiments
Zhang, T., Tian, R., Li, F., Tang, X., He, W., Hao, Z.-P., Zhuo, L., Lü, J., Lu, X., & Zheng, Y. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf274 · Cited by 5
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice
Powers, J. M., Leist, S. R., Suryadevara, N., Zost, S. J., Binshtein, E., Abdelgadir, A., Mallory, M. L., Edwards, C. E., Gully, K. L., Hubbard, M. L., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01406-25 · Cited by 5
Vaccination and COVID-19: impact on long-COVID
Guimarães, G. N., Brunetti, N. S., de Lima, D. G., Proença-Módena, J. L., & Farias, A. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1686572 · Cited by 6

Authors: Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A.
Affiliations: University of London (GB)
University of Oxford (GB)
Friedrich-Loeffler-Institut (DE)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author: Markov, Peter V.
Katzourakis, Aris
ORCID: Markov, Peter V.
Ghafari, Mahan
Beer, Martin
Lythgoe, Katrina
Stilianakis, Nikolaos I.
Katzourakis, Aris
Venue: Nature Reviews Microbiology
Publisher: Springer Science and Business Media LLC
Published: 2023-04-05
Volume: 21
Issue: 6
Pages: 361-379
ISSN: 1740-1526 (ISSN-L)
1740-1534
DOI: 10.1038/s41579-023-00878-2
OpenAlex: W4362609000
Semantic Scholar: b6c3324e790174aac7a7b28fcfe0bc22f5461418
Cited by: 1,179
References: 225
Citations by year: 2026: 204 · 2025: 390 · 2024: 441 · 2023: 130
FWCI: 55.63
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Microbiology (publishedVersion)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
OpenAgrar (submittedVersion)
Funders: Wellcome Trust (107652/Z/15/Z)
H2020 European Research Council (101001623)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, viral evolution, genetic variation, variants of concern, antigenic evolution, immune evasion, reinfection, recombination, chronic infection, reservoir hosts, transmissibility, disease severity, COVID-19 pandemic, evolutionary trajectories
MeSH terms: COVID-19, SARS-CoV-2, Animals, Genomics, Immune Evasion, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The evolution of SARS-CoV-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks